Goodwill and Intangible Assets Tables (Tables)
|
12 Months Ended |
Dec. 31, 2020 |
Goodwill and Intangible Assets Disclosure [Abstract] |
|
Schedule of Goodwill [Table Text Block] |
The following table presents the changes in the carrying amount of goodwill for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
2020 |
|
2019 |
|
(in thousands) |
Beginning balance |
$ |
238,330 |
|
|
$ |
238,330 |
|
Acquisitions (Note 3) |
64,498 |
|
|
— |
|
|
|
|
|
|
|
|
|
Ending balance |
$ |
302,828 |
|
|
$ |
238,330 |
|
|
Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block] |
The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases, which continue to be amortized:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2020 |
|
December 31, 2019 |
|
Weighted Average Useful Life (in Years) |
|
Gross Carrying Amount |
|
Accumulated Amortization |
|
Net Carrying Amount |
|
Gross Carrying Value |
|
Accumulated Amortization |
|
Net Carrying Amount |
|
|
|
(in thousands) |
Licensed technology |
5.9 |
|
$ |
4,869 |
|
|
$ |
(2,006) |
|
|
$ |
2,863 |
|
|
$ |
2,156 |
|
|
$ |
(1,583) |
|
|
$ |
573 |
|
Developed technology |
6.9 |
|
304,061 |
|
|
(146,252) |
|
|
157,809 |
|
|
243,361 |
|
|
(108,522) |
|
|
134,839 |
|
Trademarks and trade names |
6.2 |
|
14,800 |
|
|
(8,818) |
|
|
5,982 |
|
|
13,800 |
|
|
(6,511) |
|
|
7,289 |
|
Customer relationships |
4.6 |
|
128,800 |
|
|
(96,047) |
|
|
32,753 |
|
|
121,100 |
|
|
(75,847) |
|
|
45,253 |
|
Non-compete covenants |
3.0 |
|
1,100 |
|
|
(1,100) |
|
|
— |
|
|
1,100 |
|
|
(1,083) |
|
|
17 |
|
Backlog |
2.4 |
|
1,300 |
|
|
(641) |
|
|
659 |
|
|
— |
|
|
— |
|
|
— |
|
|
6.2 |
|
$ |
454,930 |
|
|
$ |
(254,864) |
|
|
$ |
200,066 |
|
|
$ |
381,517 |
|
|
$ |
(193,546) |
|
|
$ |
187,971 |
|
|
Finite-lived Intangible Assets Amortization Expense [Table Text Block] |
The following table sets forth amortization expense associated with finite-lived intangible assets, which is included in the consolidated statements of operations as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
|
|
2020 |
|
2019 |
|
2018 |
|
|
|
|
|
|
Cost of net revenue |
|
|
|
|
$ |
37,784 |
|
|
$ |
33,932 |
|
|
$ |
35,821 |
|
Research and development |
|
|
|
|
5 |
|
|
48 |
|
|
150 |
|
Selling, general and administrative |
|
|
|
|
23,529 |
|
|
23,035 |
|
|
31,976 |
|
|
|
|
|
|
$ |
61,318 |
|
|
$ |
57,015 |
|
|
$ |
67,947 |
|
|
Schedule of Finite-Lived Intangible Assets [Table Text Block] |
The following table sets forth activity during the years ended December 31, 2020 and 2019 related to finite-lived intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
2020 |
|
2019 |
|
|
|
(in thousands) |
|
|
Beginning balance |
$ |
187,971 |
|
|
$ |
240,500 |
|
|
|
Acquisitions (Note 3) |
70,700 |
|
|
— |
|
|
|
Other additions |
2,799 |
|
|
86 |
|
|
|
Transfers to developed technology from IPR&D |
— |
|
|
4,400 |
|
|
|
Amortization |
(61,318) |
|
|
(57,015) |
|
|
|
Impairment losses |
(86) |
|
|
— |
|
|
|
Ending balance |
$ |
200,066 |
|
|
$ |
187,971 |
|
|
|
|
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] |
The following table presents future amortization of the Company’s finite-lived intangible assets at December 31, 2020:
|
|
|
|
|
|
|
Amortization (in thousands) |
2021 |
$ |
66,772 |
|
2022 |
48,908 |
|
2023 |
36,802 |
|
2024 |
20,804 |
|
2025 |
10,706 |
|
Thereafter |
16,074 |
|
Total |
$ |
200,066 |
|
|
Schedule of Indefinite-Lived Intangible Assets [Table Text Block] |
Indefinite-lived intangible assets consist entirely of acquired in-process research and development technology, or IPR&D. The following table sets forth the Company’s activities related to the indefinite-lived intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
2020 |
|
2019 |
|
(in thousands) |
Beginning balance |
$ |
— |
|
|
$ |
4,400 |
|
Acquisitions (Note 3) |
7,200 |
|
|
— |
|
Transfers to developed technology from IPR&D |
— |
|
|
(4,400) |
|
|
|
|
|
Ending balance |
$ |
7,200 |
|
|
$ |
— |
|
|